Back
Halozyme Therapeutics Vs. Innodata Industry Stock Comparison
Buy
65
HALO
Halozyme Therapeutics
Last Price:
$57.79
Seasonality Move:
-2.44%
Buy
72
INOD
Innodata
Last Price:
$50.15
Seasonality Move:
7.46%
Buy
65
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy, Sell or Hold?
-
The current Halozyme Therapeutics [HALO] share price is $58.01. The Score for HALO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $58.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing slight buying pressure.
INOD Stock Price Chart
HALO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 15.65 | Buy |
Relative Strength Index (14 RSI): | 63.15 | Buy |
Chaikin Money Flow: | 560818 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.54 - 56.2) | Buy |
Bollinger Bands (100): | (53.58 - 62.32) | Buy |
INOD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 13.69 | Buy |
Relative Strength Index (14 RSI): | 54.61 | Buy |
Chaikin Money Flow: | 754499 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.33 - 51.27) | Buy |
Bollinger Bands (100): | (35.67 - 50.15) | Buy |
HALO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.71 | Buy |
20-day SMA: | 54.46 | Buy |
50-day SMA: | 55.25 | Buy |
200-day SMA: | 55.4 | Buy |
8-day EMA: | 47.41 | Buy |
20-day EMA: | 28.79 | Buy |
50-day EMA: | 13.95 | Buy |
200-day EMA: | 3.86 | Buy |
INOD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.71 | Sell |
20-day SMA: | 49.14 | Buy |
50-day SMA: | 43.65 | Buy |
200-day SMA: | 38.13 | Buy |
8-day EMA: | 41.61 | Buy |
20-day EMA: | 25.44 | Buy |
50-day EMA: | 12.36 | Buy |
200-day EMA: | 3.42 | Buy |
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.06 per share, an increase this year of $1.27 per share, and an increase next year of $1.48 per share.
Innodata Earnings Growth & INOD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.06 per share, and an increase next year of $0.40 per share.
Halozyme Therapeutics Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Innodata Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |